Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year (Q33570833)

28 July 2017

Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year (English)

1 reference

28 July 2017

0 references

1 reference

FREEDMAN A

1

1 reference

PubMed ID

13701598

28 July 2017

STEINBERG VL

series ordinal

2

1 reference

PubMed ID

13701598

28 July 2017

language of work or name

English

0 references

publication date

1 September 1960

1 reference

Annals of the Rheumatic Diseases

28 July 2017

1 reference

28 July 2017

19

1 reference

28 July 2017

243-250

1 reference

Medical and Social Aspects of the Treatment of Rheumatoid Arthritis: With Special Reference to Factors Affecting Prognosis

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Use of synthetic antimalarials in primary chronic polyarthritis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Chloroquine treatment of 20 patients with active rheumatoid arthritis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Chloroquine therapy in rheumatoid arthritis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Proposed diagnostic criteria for rheumatoid arthritis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Chloroquine and rheumatoid arthritis; a short-term controlled trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Serological research in chronic inflammatory rheumatism; study of antistreptolysin O

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

A controlled study of chloroquine as an antirheumatic agent

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1007150

Retinopathy following chloroquine therapy

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/13701598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mepacrine and rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/13701598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of rheumatoid arthritis with chloroquine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/13701598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.19.3.243

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

PubMed ID

13701598